» Authors » Uttam Kumar Nath

Uttam Kumar Nath

Explore the profile of Uttam Kumar Nath including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 149
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kachhwaha A, Baveja A, Dev R, Huda F, Nath U
Cardiovasc Hematol Disord Drug Targets . 2025 Feb; PMID: 39950460
Background: Chronic myeloid leukemia [CML] is a common hematological malignancy where patients present with varied clinical symptoms and are usually diagnosed with incidentally detected elevated total leucocyte counts in hemogram....
2.
Sil S, Kaur D, Negi G, Jain A, Nath U
Indian J Hematol Blood Transfus . 2025 Feb; 41(1):127-136. PMID: 39917501
The study aimed to find out the correlation of positive direct antiglobulin test (DAT) with features of autoimmune hemolysis in patients presenting to a tertiary care center in Northern India....
3.
Kachhwaha A, Shah B, Ronanki K, Dalton P, Nath U
Cardiovasc Hematol Disord Drug Targets . 2024 Nov; 24(4):266-270. PMID: 39482910
Background: Thromboembolism with solid malignancies is a commonly associated feature, which is less common in hematological malignancies. Disseminated intravascular coagulation (DIC) causing thrombotic events is characteristically associated with certain hematological...
4.
Jindal U, Mamgain M, Nath U, Sharma I, Pant B, Sharma A, et al.
Leukemia . 2024 Jul; 38(9):2070-2071. PMID: 39075199
No abstract available.
5.
Nayak J, Kumar K, Singh S, Dhingra G, Nath U
Oman Med J . 2024 Jul; 39(3):e634. PMID: 39015429
Methemoglobinemia is a rare dyshemoglobin disorder which can either be congenital or acquired. Dyshemoglobin disorders can be asymptomatic or symptomatic. We narrate the case of a 12-year-old girl who presented...
6.
Jindal U, Mamgain M, Nath U, Sharma I, Pant B, Sharma A, et al.
Leukemia . 2024 Jul; 38(10):2196-2209. PMID: 39003397
The interaction between stromal and tumor cells in tumor microenvironment is a crucial factor in Mantle cell lymphoma (MCL) progression and therapy resistance. We have identified a long non-coding RNA,...
7.
Agnihotri A, Ramasubbu S, Bandyopadhyay A, Bidarolli M, Nath U, Das B
Cureus . 2024 Jun; 16(5):e60492. PMID: 38882995
Introduction Cancer chemotherapy regimens include multiple classes of adjuvant drugs as supportive therapy. Because of the concurrent intake of other drugs (like antiemetics, antidepressants, analgesics, and antimicrobials), there is a...
8.
Vardhan G, Kumar V, Sahu P, Prakash A, Prasad R, Handu S, et al.
J Chromatogr Sci . 2024 May; 62(7):611-617. PMID: 38745428
In the present work, new chiral stationary phase high-performance liquid chromatography (CSP-HPLC) method was established and validated for the quantification of pomalidomide (PMD) enantiomers in human plasma. The chromatographic enantiomeric...
9.
Chatzikonstantinou T, Scarfo L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, et al.
EClinicalMedicine . 2023 Nov; 65:102307. PMID: 38033506
Background: Patients with chronic lymphocytic leukemia (CLL) have a higher risk of developing other malignancies (OMs) compared to the general population. However, the impact of CLL-related risk factors and CLL-directed...
10.
Batra A, Hazarika N, Nath U
Indian Dermatol Online J . 2023 Sep; 14(5):630-636. PMID: 37727568
Background: Cutaneous manifestations of hematological neoplasms can be divided into three broad categories - direct infiltration, paraneoplastic conditions, and those due to the treatment of hematological cancers. Objectives: To study...